Emerging fluoroquinolone resistance in Neisseria meningitidis in India: Cause for concern [5]

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 2, 2007, Pages 329-330

  Mehta, Geet ^a   Goyal, Renu ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Chemoprophylaxis; MICs; Surveillance

Indexed keywords

AGAR; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; PENICILLIN G; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFADIAZINE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD GROUP TYPING; CHROMOSOME MUTATION; CONTROLLED STUDY; DRUG MONITORING; EPIDEMIC; HUMAN; INDIA; LETTER; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; PATIENT REFERRAL; TEACHING HOSPITAL; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION;

DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; INDIA; MENINGOCOCCAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; MUTATION; NEISSERIA MENINGITIDIS;

EID: 33947536965     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl484     Document Type: Letter

References (8)

1. Manchanda V, Gupta P, Bhalla P. Meningococcal disease: History, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention. Indian J Med Microbiol 2006; 24: 7-19.
2. Dworzack DL, Sanders CC, Horowitz EA et al. Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carders. Antimicrob Agents Chemother 1988; 32: 1740-1.
3. Shultz TR, White PA, Tapsall JW. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis. Antimicrob Agents Chemother 2005; 49: 1753-60.
4. Kaczmarski EB, Gray SJ, Carr AD et al. Antimicrobial agent susceptibility of clinical Neisseria meningitidis isolates from England and Wales. In: Abstracts of the Thirty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA, 1999. Abstract 1466. American Society for Microbiology, Washington, DC, USA.
5. Casin I, Gandry B, Lassau F et al. Decreased susceptibility to penicillin G, tetracyclines and fluoroquinolones and characterisation of DNA gyrase mutations, in oropharyngeal and anogenital isolates of Neisseria meningitidis (Nme) in patients presenting at an STD clinic. In: Abstracts of the Thirty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA, 1999. Abstract 2101. American Society for Microbiology, Washington, DC, USA.
6. Communicable Diseases Department, WHO Regional Office for South-East Asia. Meningococcal disease in India, Epidemic and pandemic alert response (EPR), CD alert 2005.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: M100-S15. CLSI, Wayne, PA, USA, 2005.
8. Sarkar R, Sharma S, Natarajan R et al. Sulphadiazine resistant group 'A' meningococci isolated during the meningitis outbreak in Delhi (1985). Ind J Med Res 1987; 85: 612-6.